As of Oct 20
| 0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for AngioDynamics Inc have a median target of 17.75, with a high estimate of 20.00 and a low estimate of 16.00. The median estimate represents a +2.54% increase from the last price of 17.31.
The current consensus among 5 polled investment analysts is to Hold stock in AngioDynamics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.